Stage III breast cancer ajcc V6

Clinical trials for Stage III breast cancer ajcc V6 explained in plain language.

Never miss a new study

Get alerted when new Stage III breast cancer ajcc V6 trials appear

Sign up with your email to follow new studies for Stage III breast cancer ajcc V6, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a Tumor-Blood-Vessel blocker boost hormone therapy for advanced breast cancer?

Disease control Completed

This phase III trial asks whether adding bevacizumab to standard hormone therapy (tamoxifen or letrozole) helps women with hormone receptor-positive advanced breast cancer live longer without the disease worsening. Hormone therapy blocks estrogen, which fuels tumor growth, while …

Matched conditions: STAGE III BREAST CANCER AJCC V6

Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 30, 2026 00:00 UTC

Stage III breast cancer ajcc V6

Get alerted when new Stage III breast cancer ajcc V6 trials appear

Can a Tumor-Blood-Vessel blocker boost hormone therapy for advanced breast cancer?